Published in Biotechniques on April 01, 1994
Octamer-primed sequencing technology: development of primer identification software. Nucleic Acids Res (2000) 0.81
DNA sequencing using differential extension with nucleotide subsets (DENS). Nucleic Acids Res (1997) 0.79
Pain intensity processing within the human brain: a bilateral, distributed mechanism. J Neurophysiol (1999) 3.27
Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron (1994) 2.61
Analysis of the native quaternary structure of vanilloid receptor 1. J Biol Chem (2001) 2.55
A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates. J Infect Dis (1975) 2.14
Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. Proc Natl Acad Sci U S A (1991) 2.04
Recombinant proteins attached to a nickel-NTA column: use in affinity purification of antibodies. Biotechniques (1994) 1.62
Genetic predictors for acute experimental cold and heat pain sensitivity in humans. J Med Genet (2006) 1.62
Substantia nigra: site of anticonvulsant activity mediated by gamma-aminobutyric acid. Science (1982) 1.60
Ligand-induced dynamic membrane changes and cell deletion conferred by vanilloid receptor 1. J Biol Chem (2000) 1.59
Genomic integration and gene expression by a modified adenoviral vector. Nat Biotechnol (2000) 1.55
Hemispheric lateralization of somatosensory processing. J Neurophysiol (2001) 1.35
Excitatory amino acid recognition sites coupled with inositol phospholipid metabolism: developmental changes and interaction with alpha 1-adrenoceptors. Proc Natl Acad Sci U S A (1986) 1.34
Coupling of inositol phospholipid metabolism with excitatory amino acid recognition sites in rat hippocampus. J Neurochem (1986) 1.26
Anandamide activates vanilloid receptor 1 (VR1) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing VR1. J Biol Chem (2001) 1.26
Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum. Eur J Neurosci (1996) 1.20
In situ hybridization histochemistry and immunocytochemistry reveal an increase in spinal dynorphin biosynthesis in a rat model of peripheral inflammation and hyperalgesia. Proc Natl Acad Sci U S A (1988) 1.14
A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain. Hum Gene Ther (1999) 1.13
Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms. Eur J Pharmacol (1991) 1.09
Cloning of a DNA binding protein that is a tyrosine kinase substrate and recognizes an upstream initiator-like sequence in the promoter of the preprodynorphin gene. Brain Res Mol Brain Res (1994) 1.07
Rat brain protein kinase C: purification, antibody production, and quantification in discrete regions of hippocampus. J Neurochem (1989) 1.05
Monocyte chemoattractant protein-1 in the choroid plexus: a potential link between vascular pro-inflammatory mediators and the CNS during peripheral tissue inflammation. Neuroscience (2008) 1.05
Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Brain Res Mol Brain Res (1989) 1.04
Dynorphin expression and Fos-like immunoreactivity following inflammation induced hyperalgesia are colocalized in spinal cord neurons. Brain Res Mol Brain Res (1991) 1.04
Dynorphin increases in the dorsal spinal cord in rats with a painful peripheral neuropathy. Peptides (1990) 1.02
Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation. Brain Res (1991) 1.00
Fos-like proteins in the lumbosacral spinal cord following noxious and non-noxious colorectal distention in the rat. Pain (1992) 0.99
Salivary anti-Ro60 and anti-Ro52 antibody profiles to diagnose Sjogren's Syndrome. J Dent Res (2011) 0.98
Stress selectively increases fos protein in dopamine neurons innervating the prefrontal cortex. Cereb Cortex (1992) 0.97
Transcription factor regulation of prodynorphin gene expression following rat hindpaw inflammation. Brain Res Mol Brain Res (1998) 0.96
Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action. Mol Cell Neurosci (1992) 0.93
Patterns of epithelial expression of Fos protein suggest important role in the transition from viable to cornified cell during keratinization. Development (1991) 0.93
Adenoviral gene transfer to spinal-cord neurons: intrathecal vs. intraparenchymal administration. Brain Res (1998) 0.90
Effects of D2 dopamine receptor antagonists on Fos protein expression in the striatal complex and entorhinal cortex of the nonhuman primate. Synapse (1996) 0.89
Changes in dynorphin, enkephalin and cholecystokinin content of hippocampus and substantia nigra after amygdala kindling. Brain Res (1986) 0.89
Cellular compartments of GABA in brain and their relationship to anticonvulsant activity. Mol Cell Biochem (1981) 0.88
UREB1, a tyrosine phosphorylated nuclear protein, inhibits p53 transactivation. Oncogene (1995) 0.88
Actions of intrathecal diphtheria toxin-substance P fusion protein on models of persistent pain. Pain (1999) 0.88
Epidural resiniferatoxin induced prolonged regional analgesia to pain. Brain Res (1999) 0.87
Seizure protection and increased nerve-terminal GABA: delayed effects of GABA transaminase inhibition. Science (1980) 0.87
Peripheral inflammation is associated with increased dynorphin immunoreactivity in both projection and local circuit neurons in the superficial dorsal horn of the rat lumbar spinal cord. Neurosci Lett (1989) 0.86
Basal and inducible transcriptional activity of an upstream AP-1/CRE element (DYNCRE3) in the prodynorphin promoter. Mol Cell Neurosci (1994) 0.86
Fos-like immunoreactivity increases in the lumbar spinal cord following a chronic constriction injury to the sciatic nerve of rat. Neurosci Lett (1996) 0.85
c-Fos expression in NMDA receptor-contained neurons in spinal cord in a rat model of inflammation: a double immunocytochemical study. Brain Res (1998) 0.85
Differential induction of Fos protein and a Fos-related antigen following acute and repeated cocaine administration. Brain Res Mol Brain Res (1994) 0.85
Immunohistochemical localization of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor subunits in the substantia nigra pars compacta of the rat. Neuroscience (1999) 0.84
Spinal cord genes enriched in rat dorsal horn and induced by noxious stimulation identified by subtraction cloning and differential hybridization. Neuroscience (2001) 0.83
Effect of multiple dorsal rhizotomies on calcitonin gene-related peptide-like immunoreactivity in the lumbosacral dorsal spinal cord of the cat: a radioimmunoassay analysis. Peptides (1990) 0.82
Intrathecally administered cholera toxin blocks allodynia and hyperalgesia in persistent pain models. J Pain (2001) 0.82
GR89,696 is a kappa-2 opioid receptor agonist and a kappa-1 opioid receptor antagonist in the guinea pig hippocampus. J Pharmacol Exp Ther (1997) 0.82
Spinal kappa1 and kappa2 opioid binding sites in rats, guinea pigs, monkeys and humans. Neuroreport (1998) 0.82
Co-localization of N-methyl-D-aspartate receptors and substance P (neurokinin-1) receptors in rat spinal cord. Neurosci Lett (2000) 0.82
New technologies for studying the complexity of oral diseases. Oral Dis (2011) 0.82
Electrical stimulation of visceral afferent pathways in the pelvic nerve increases c-fos in the rat lumbosacral spinal cord. Neurosci Lett (1991) 0.82
An isobolographic analysis of the effects of N-methyl-D-aspartate and NK1 tachykinin receptor antagonists on inflammatory hyperalgesia in the rat. Br J Pharmacol (1996) 0.81
Global cerebral blood flow decreases during pain. J Cereb Blood Flow Metab (1998) 0.81
NMDAR1 glutamate receptor subunit isoforms in neostriatal, neocortical, and hippocampal nitric oxide synthase neurons. J Neurosci (1998) 0.81
Stimulation of adrenal medullary cells in vivo and in vitro induces expression of c-fos proto-oncogene. Oncogene (1990) 0.81
Analgesic activity and release of [MET5]enkephalin-Arg6-Gly7-Leu8 from rat spinal cord in vivo. Eur J Pharmacol (1986) 0.80
Localization of alternatively spliced NMDAR1 glutamate receptor isoforms in rat striatal neurons. J Comp Neurol (1999) 0.80
A kinetic analysis of substance P trafficking. J Pharm Sci (2003) 0.80
Changes in the dynamic state of brain proenkephalin-derived peptides during amygdaloid kindling. J Neurosci Res (1986) 0.79
Substance P antagonists in substantia nigra are anticonvulsant. Brain Res (1986) 0.79
Chronic tooth pulp inflammation causes transient and persistent expression of Fos in dynorphin-rich regions of rat brainstem. Brain Res (2000) 0.79
Transcriptional regulation of the rat prodynorphin gene. NIDA Res Monogr (1991) 0.78
GABAergic denervation of rat substantia nigra: functional and pharmacological properties. Brain Res (1980) 0.78
Distribution of Met5-enkephalin-Arg6, Phe7 in rat spinal cord. Brain Res (1983) 0.78
URE, an initiator (Inr)-like site, suppresses the promoter of the rat dynorphin gene. Biochem Biophys Res Commun (1997) 0.78
Abnormality of alpha 1-adrenergic receptors in the frontal cortex of epileptic rats. J Neurochem (1986) 0.78
c-Jun activation of the DYNCRE3 site in the prodynorphin promoter. Brain Res Mol Brain Res (1996) 0.78
Decreased [3H]-naloxone binding and elevated dynorphin-A(1-8) content in Zucker rat brain. Physiol Behav (1988) 0.78
In vivo control of NMDA receptor transcript level in motoneurons by viral transduction of a short antisense gene. Brain Res Mol Brain Res (2001) 0.78
Serine-O-phosphate, an endogenous metabolite, inhibits the stimulation of inositol phospholipid hydrolysis elicited by ibotenic acid in rat hippocampal slices. Neuropharmacology (1986) 0.77
Activation of spinal neuropeptide FF and the neuropeptide FF receptor 2 during inflammatory hyperalgesia in rats. Neuroscience (2003) 0.77
Dissociation between drug-induced increases in nerve terminal and non-nerve terminal pools of GABA in vivo. Eur J Pharmacol (1979) 0.76
Effect of peptidase inhibitors on [Met5]enkephalin-Arg6-Phe7 and [Met5]enkephalin-Arg6-Gly7-Leu8-induced antinociception. Eur J Pharmacol (1987) 0.76
Cholecystokinin turnover in brain. Brain Res (1983) 0.76
Effect of administration of high dose intrathecal clonidine or morphine prior to sciatic nerve section on c-Fos expression in rat lumbar spinal cord. Neuroscience (1995) 0.76
Opioid peptides in Parkinson's disease: effects of dopamine repletion. Brain Res (1991) 0.76
The opioid octapeptide Met5-enkephalin-Arg6-Gly7-Leu8: characterization and distribution in rat spinal cord. Brain Res (1985) 0.76
Unexpectedly high levels of opioid peptides in rat brain membranes. Peptides (1987) 0.75
Anticonvulsant action of GABAergic drugs: cellular and anatomical localization of their site of action in vivo. Prog Clin Biol Res (1983) 0.75
Regulation of the expression of proenkephalin mRNA in bovine adrenal chromaffin cells: Role of proto-oncogenes. Mol Cell Neurosci (1992) 0.75
Primary afferent and sacral dorsal horn neuron responses to vaginal probing in the cat. Neurosci Lett (1981) 0.75
Inhibition of Met5-enkephalin-Arg6-Phe7 degradation by inhibitors of dipeptidyl carboxypeptidase. J Pharmacol Exp Ther (1986) 0.75
Comparison of the effects of diphenylbarbituric acid, phenobarbital, pentobarbital and secobarbital on GABA-mediated inhibition and benzodiazepine binding. J Pharmacol Exp Ther (1985) 0.75
Co-localization of the beta-subtype of protein kinase C and phosphorylation-dependent immunoreactivity of neurofilaments in intact, decentralized and axotomized rat peripheral neurons. J Neurocytol (1993) 0.75
Differential effects of n-dipropylacetate and amino-oxyacetic acid on gamma-aminobutyric acid levels in discrete areas of rat brain. J Neurochem (1979) 0.75
Destruction of the nigrostriatal pathway increases Fos-like immunoreactivity predominantly in striatopallidal neurons. Brain Res Mol Brain Res (1993) 0.75
Immunohistochemical distribution of beta-protein kinase C in rat hippocampus determined with an antibody against a synthetic peptide sequence. Brain Res Bull (1989) 0.75
Release of [met5]-enkephalin-arg6-gly7-leu8 immunoreactivity into rat cerebrospinal fluid by electroconvulsive shock. Biochem Pharmacol (1987) 0.75
Peripheral and central origin of Phe-Met-Arg-Phe-amide immunoreactivity in rat spinal cord. Regul Pept (1986) 0.75
Focal c-fos expression in developing rat molars: correlations with subsequent intradental and epithelial sensory innervation. Int J Dev Biol (1995) 0.75
Expression of the cholecystokinin gene in rat brain during development. Dev Neurosci (1987) 0.75
Blockade of the tonic hindlimb extensor component of maximal electroshock and pentylenetetrazol-induced seizures by drugs acting on muscle and muscle spindle systems: a perspective on method. Epilepsia (1976) 0.75
A 35 kDa Fos-related antigen is co-localized with substance P and dynorphin in striatal neurons. Brain Res (1992) 0.75